vapetrinity.com — FDA Compliance Timeline

FDA action counts

Enforcement history

On 2026-05-19, Argus HQ recorded an FDA Warning Letter for vapetrinity.com, rated "critical" severity in Argus HQ's classification: vapetrinity.com — Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded (2026-05-19). Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Risk pattern analysis

Argus HQ analysis — not an FDA finding

This section is Argus HQ analysis, not an FDA finding. vapetrinity.com has 1 FDA event on file. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Frequently asked questions

Does Argus HQ track new FDA actions for vapetrinity.com automatically?

Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to vapetrinity.com is observed, this page's event count and history update automatically.

How many FDA actions does Argus HQ track for vapetrinity.com?

1 total: 1 warning letter, 0 recalls, 0 approval records, and 0 Form 483 inspection citations.

What is the most recent FDA action on file for vapetrinity.com?

May 19, 2026. Argus HQ ingests new FDA enforcement records daily.

Has vapetrinity.com received FDA warning letters?

Yes, 1 warning letter on file. See the full history below for each one.

Related enforcement actions

• vapetrinity.com — Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded (2026-05-19) →

Compare with

• vapetrinity.com vs Medline Industries, LP
• vapetrinity.com vs ARROW INTERNATIONAL, LLC
• vapetrinity.com vs Stryker Sustainability Solutions
• vapetrinity.com vs Guardian Drug Co. Inc.
• vapetrinity.com vs B BRAUN MEDICAL INC